To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04586426
Title A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Acronym RedirecTT-1
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR | ESP | CAN | AUS

Facility Status City State Zip Country Details
University of Alabama at Birmingham, Comprehensive Cancer Center Birmingham Alabama 35233 United States Details
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 United States Details
Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
Emory University Atlanta Georgia 30322 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Washington University St. Louis School Medicine Siteman Cancer Center Saint Louis Missouri 63108 United States Details
Mount Sinai Medical Center New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Atrium Health Charlotte North Carolina 28204 United States Details
Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center Winston-Salem North Carolina 27157 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Oregon Health And Science University Portland Oregon 97239 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
St Vincents Hospital Melbourne Fitzroy 3065 Australia Details
Royal Perth Hospital Perth 6000 Australia Details
Arthur J E Child Comprehensive Cancer Centre Calgary Alberta T2N 5G2 Canada Details
Alberta Health Services Edmonton Alberta T6G 1Z2 Canada Details
Princess Margaret Cancer Centre University Health Network Toronto Ontario M5G 1X6 Canada Details
McGill University Health Centre Montreal Quebec H4A 3J1 Canada Details
Hadassah Medical Center Jerusalem 91120 Israel Details
Sheba Medical Center Ramat Gan 52621 Israel Details
Tel Aviv Sourasky Medical Center Tel-Aviv 64239 Israel Details
Kanazawa University Hospital Kanazawa 920-8641 Japan Details
Nagoya City University Hospital Nagoya 467 8602 Japan Details
Osaka University Hospital Osaka 565-0871 Japan Details
Tohoku University Hospital Sendai shi 980 8574 Japan Details
Japanese Red Cross Medical Center Shibuya 150-8935 Japan Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Severance Hospital Yonsei University Health System Seoul 03722 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
Samsung Medical Center Seoul 06351 Korea, Republic of Details
The Catholic University of Korea Seoul St Marys Hospital Seoul 06591 Korea, Republic of Details
Hosp. Univ. Germans Trias I Pujol Badalona 08916 Spain Details
Hosp Clinic de Barcelona Barcelona 08036 Spain Details
Inst. Cat. Doncologia-H Duran I Reynals L Hospitalet De Llobregat 08908 Spain Details
Hosp Univ Fund Jimenez Diaz Madrid 28040 Spain Details
UNIV. HOSP. October 12 Madrid 28041 Spain Details
Clinica Univ. de Navarra Pamplona 31008 Spain Details
Hosp Clinico Univ de Salamanca Salamanca 37007 Spain Details
Hosp. Univ. Marques de Valdecilla Santander 39008 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field